Richard Geary
Vermögen: 5 Mio $ am 31.05.2026
Vermögen: 5 Mio $ am 31.05.2026
Richard S.
Geary is currently Director at Oligonucleotide Therapeutics Society, Inc. Formerly, Dr. Geary was Vice President-Preclinical Development at Ionis Pharmaceuticals, Inc. from 2003 to 2008 and worked at Southwest Research Institute as Senior Research Scientist.
Education includes undergraduate studies at Texas A&M University and a doctorate from The University of Texas at Austin conferred in 1987.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 59.657 ( 0,04 % ) | 5 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2026 |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen